Standard-Dose Influenza Vaccine

BIOLOGICAL2 trials

Sponsors

Tor Biering-Sørensen, Korea University Guro Hospital

Conditions

Immune ResponseInfluenzaInfluenza VaccinesMicrobiome

Phase 4

Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes

CompletedNCT06506812

Tor Biering-SørensenInfluenza

Start: 2025-05-31End: 2025-08-31Updated: 2025-09-12

Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults

CompletedNCT07805837

Korea University Guro HospitalImmune Response, Influenza, Influenza Vaccines +1

Start: 2025-10-25End: 2026-08-31Updated: 2026-09-04

Related Papers

Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.

2025-10-17